Medcart Specialties(India) Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 10-12-2024
- Paid Up Capital ₹ 0.10 M
as on 10-12-2024
- Company Age 5 Year, 2 Months
- Last Filing with ROC 31 Mar 2020
About Medcart Specialties(India)
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2020. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Neeraj Rastogi and Sheenu Rastogi serve as directors at the Company.
- CIN/LLPIN
U74999UR2019PTC010395
- Company No.
010395
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
08 Nov 2019
- Date of AGM
31 Dec 2020
- Date of Balance Sheet
31 Mar 2020
- Listing Status
Unlisted
- ROC Code
Roc Uttarakhand
Industry
Company Details
- Location
Dehradun, Uttarakhand, India
- Telephone
- Email Address
- Website
-
- Social Media-
What products or services does Medcart Specialties(India) Private Limited offer?
Medcart Specialties(India) Private Limited offers a wide range of products and services, including Anti Infective Drugs & Medicines, Antiviral Drugs, Common Disease Medicines, Injectable Products, Nutraceuticals & Dietary Supplements, Dietary Supplements, TB, Tumor & Cancer Drugs, Anti Cancer Medicines, Cardiovascular Drugs & Medication, Anaemia Medicine.
Who are the key members and board of directors at Medcart Specialties(India)?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sheenu Rastogi  | Director | 10-Jul-2020 | Current |
| Neeraj Rastogi | Director | 08-Nov-2019 | Current |
Financial Performance of Medcart Specialties(India).
Enhance accessibility to Medcart Specialties(India)'s financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Medcart Specialties(India)?
Unlock access to Medcart Specialties(India)'s control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Medcart Specialties(India)?
Unlock and access historical data on people associated with Medcart Specialties(India), such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Medcart Specialties(India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Medcart Specialties(India)'s trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
